Supporting patients in their withdrawal

Addictions, whether linked to nicotine or cannabis, have devastating effects on the health and well-being of individuals. At BIKY Pharma, we are determined to support patients in their weaning journey by developing innovative solutions that combine science and technology to offer them concrete results.

Smoking cessation
A breakthrough solution combining nicotine and CBD

Smoking cessation is one of the major challenges for many people addicted to nicotine. To meet this need, BIKY Pharma has developed a unique formulation combining nicotine and cannabidiol (CBD). This combination acts on the receptors of the endocannabinoid system, helping to reduce withdrawal symptoms and irresistible cravings. CBD has demonstrated its relaxing and anxiolytic properties, making it a valuable asset in helping patients manage the stressful moments often linked to quitting smoking. Thanks to our vaporization technology, we enable precise administration, adjusted to individual needs, offering an effective alternative to traditional nicotine replacement methods.

Towards an integrated approach to cannabis withdrawal

We will also extend our expertise to cannabis withdrawal, a rapidly growing problem as the use of recreational cannabis increases.
Cannabis withdrawal can be accompanied by symptoms such as irritability, anxiety, trouble sleeping, and a strong desire to use again.

To help patients overcome these obstacles, BikyPharma is developing a therapeutic approach that will include tailored formulations, combined with our vaporization device, to target the underlying mechanisms of addiction and reduce withdrawal effects in a gradual and controlled manner.

A new era for addiction treatment

At BIKY Pharma, we are convinced that technological innovation, combined with an in-depth understanding of the mechanisms of addiction, is the key to transforming withdrawal management. Our vaporization solutions allow controlled delivery and unprecedented flexibility to adjust treatments based on individual needs. By pushing the boundaries of conventional treatments, we strive to make the cessation journey more accessible, more effective and more comfortable for all patients.